[Complement lysis sensitivity test (CLS test)].
Uchiyama Y.
Nihon Rinsho. 1997 Mar;55 Suppl 1:149-52.
Complement-mediated fragmentation and lysis of opsonized platelets: ender differences in sensitivity.
Horstman LL, Jy W, Schultz DR, Mao WW, Ahn YS.
J Lab Clin Med. 1994 Apr;123(4):515-25.
36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016.
Bateman RM, Sharpe MD, Jagger JE, Ellis CG, Solé-Violán J, López-Rodríguez M, Herrera-Ramos E, Ruíz-Hernández J, Borderías L, Horcajada J, González-Quevedo N, Rajas O, Briones M, Rodríguez de Castro F, Rodríguez Gallego C, Esen F, Orhun G, Ergin Ozcan P, Senturk E, Ugur Yilmaz C, Orhan N, Arican N, Kaya M, Kucukerden M, Giris M, Akcan U, Bilgic Gazioglu S, Tuzun E, Riff R, Naamani O, Douvdevani A, Takegawa R, Yoshida H, Hirose T, Yamamoto N, Hagiya H, Ojima M, Akeda Y, Tasaki O, Tomono K, Shimazu T, Ono S, Kubo T, Suda S, Ueno T, Ikeda T, Hirose T, Ogura H, Takahashi H, Ojima M, Kang J, Nakamura Y, Kojima T, Shimazu T, Ikeda T, Suda S, Izutani Y, Ueno T, Ono S, Taniguchi T, O M, Dinter C, Lotz J, Eilers B, Wissmann C, Lott R, Meili MM, Schuetz PS, Hawa H, Sharshir M, Aburageila M, Salahuddin N, Chantziara V, Georgiou S, Tsimogianni A, Alexandropoulos P, Vassi A, Lagiou F, Valta M, Micha G, Chinou E, Michaloudis G, Kodaira A, Ikeda T, Ono S, Ueno T, Suda S, Izutani Y, Imaizumi H, De la Torre-Prados MV, Garcia-De la Torre A, Enguix-Armada A, Puerto-Morlan A, Perez-Valero V, Garcia-Alcantara A, Bolton N, Dudziak J, Bonney S, Tridente A, Nee P, Nicolaes G, Wiewel M, Schultz M, Wildhag…
Crit Care. 2016 Apr 20;20(Suppl 2):94. doi: 10.1186/s13054-016-1208-6.
Differences in the sensitivity of tumor cells and normal lymphocytes toward lysis by alloantibodies and guinea pig or rabbit complement.
Young-Rodenchuk JM, Gyenes L.
Transplantation. 1975 Jul;20(1):20-5. doi: 10.1097/00007890-197507000-00004.
[Xenodiagnosis, hemoculture and the complement mediated lysis test, as criteria in selecting chronic chagasic patients for chemotherapy].
Pereira VL, Levy AM, Boainain E.
Rev Inst Med Trop Sao Paulo. 1989 Sep-Oct;31(5):301-7. doi: 10.1590/s0036-46651989000500002.
Complement-dependent cellular cytotoxicity: lymphoblastoid lines that activate complement component 3 (C3) and express C3 receptors have increased sensitivity to lymphocyte-mediated lysis in the presence of fresh human serum.
Ramos OF, Sármay G, Klein E, Yefenof E, Gergely J.
Proc Natl Acad Sci U S A. 1985 Aug;82(16):5470-4. doi: 10.1073/pnas.82.16.5470.
Laboratory diagnosis of paroxysmal nocturnal hemoglobinuria.
Krauss JS.
Ann Clin Lab Sci. 2003 Fall;33(4):401-6.
Drug-concentration dependent sensitivity to lysis by antibody and complement, of adriamycin- or mitomycin-treated murine lymphoma cells.
Leroux JY, Mercier G, Oth D.
Int J Immunopharmacol. 1987;9(2):191-7. doi: 10.1016/0192-0561(87)90094-4.
Characterization of the complement sensitivity of calcium loaded human erythrocytes.
Test ST, Bütikofer P, Yee MC, Kuypers FA, Lubin B.
Blood. 1991 Dec 1;78(11):3056-65.
Resistance to complement-mediated lysis of parainfluenza virus 5-infected cells is acquired after transition from acute to persistent infection.
Fox CR, Yousef NN, Varudkar N, Shiffer EM, Aquino JR, Kedarinath K, Parks GD.
J Virol. 2025 Feb 25;99(2):e0189524. doi: 10.1128/jvi.01895-24. Epub 2025 Jan 10.
